Farms.com Home   Ag Industry News

US succeeds in GM corn trade dispute

Jan 03, 2025
By Farms.com

Mexico challenges GM corn import ruling

The US-Mexico-Canada Agreement (USMCA) trade panel has ruled in favor of the United States, stating that Mexico’s ban on genetically modified (GM) corn violates trade regulations due to a lack of adequate scientific risk assessments.

While Mexico has vowed to respect the ruling, it maintains its opposition to GM corn, citing health and biodiversity risks.

The ruling stems from Mexico’s 2023 presidential decree banning GM corn and glyphosate to protect native maize biodiversity and public health. Mexican organizations argue the panel lacks the expertise to assess the health and environmental impacts of GM corn.

"It demonstrates the risks that basic foodstuffs are part of trade agreements and are considered as a commodity and not as a priority good for humanity," emphasised the Sin Maíz No Hay País campaign.

The campaign also highlights the absence of credible evidence from US industry regarding the safety of GM corn, accusing companies of evading rigorous testing. Mexico has proposed a joint risk assessment with the US, but the offer was declined.

Corn holds cultural and agricultural significance in Mexico, home to 64 maize breeds. The government’s defence stressed the need to protect native corn diversity from GM contamination, which has reportedly increased from 1% in 2009 to 33% in 2023, according to a Conahcyt study.

Despite the ruling, Mexico’s stance remains firm, with ongoing efforts to constitutionally ban GM corn planting and consumption. Advocates continue to push for biosafety measures and raise awareness about the risks of transgenic crops.


Trending Video

A new era in biostimulants and bionutritionals

Video: A new era in biostimulants and bionutritionals


In response to the growing need for efficient, effective biosolutions, HGS BioScience continues to expand its footprint in the bionutritional and biostimulant market with the acquisition of NutriAg, Ltd. The Paine Schwartz Partners-backed HGS BioScience is a global leader in humic and fulvic acid products. Toronto-based NutriAg is an innovator in bionutritional technologies with a deep R&D engine. North American growers and retailers will benefit from:

• Solutions across the biostimulant spectrum - including humics, fulvics, bionutritionals, carbohydrate chelation, amino acids, plant and seaweed extracts, and microbial technologies.
• A portfolio and R&D pipeline of science-backed solutions proven to drive crop productivity and farm profitability.
• Actionable nutrient insights and recommendations based on data specific to their farm and cropping goals with the NutriAnalytics platform